Eric B. Sheinin, PhD

home / authors / eric-b-sheinin-phd

Eric Sheinin is the president of Sheinin and Associates, 13917 Bergenfield Dr., North Potomac, MD 20878, tel. 301.424.2606, fax 301.424.2831. He also is a member of Pharmaceutical Technology’s editorial advisory board.

Articles

Site Logo

USP's Semi-Hemiquinquennial Meeting

Eric B. Sheinin, PhD
June 2nd 2004

A recent USP gathering generated creative suggestions for the March 2005 USP convocation.

Site Logo

A State of Revision: USP's Guideline for the Submission of Requests for Revision

Eric B. Sheinin, PhD
December 2nd 2003

USP's new guideline will assist the industry to help set the monograph standards by which the industry must abide. This column suggests how to apply the guideline to gain maximum benefit.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: August 21st 2024 | Updated: December 27th 2024
Pharmaceutical Technology Editorial Advisory Board
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: November 25th 2024 | Updated: December 27th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: December 20th 2024 | Updated: December 27th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Europa Perspectives: Helping to Navigate the Regulatory System
Published: February 23rd 2024 | Updated: December 27th 2024
Europa Perspectives: Helping to Navigate the Regulatory System